SEC Form 5 · accession 0001387131-18-000565
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G Finizio
Officer — CEO · Director · 10% Owner
Period of report
Dec 31, 2017
Accepted (ET)
Feb 12, 2018 · 9:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2017 | G | 250,000 | $0.00 | D | 18,393,559 | D | |
| Common StockF1 | holding | — | — | — | 1,630,090 | I | See footnote | |
| Common StockF2,F3 | holding | — | — | — | 369,910 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1By the reporting person's Grantor-Retained Annuity Trust (the "GRAT").
- F2Includes 197,350 shares of common stock previously reported as being held indirectly by the GRAT.
- F3By Robert Finizio Revocable Trust.